← Leaderboards
Stefan M Schieke
U.S. Dept/Vets Affairs Medical Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2021–23$1$1$1$0$0
'21
'22
'23
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Advanced Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Kimberly Smith · Ppd Development Lp$116,656,661
- Klaus Romero · Critical Path Institute$88,602,036
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$59,913,818
Research focus
Advanced DiseaseAgent OrangeAutomobile DrivingAffectBiologyCancer CellCell LineCell MotilityCellsBehaviorChronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia CellCitric Acid CycleDesignDisease ProgressionEffective TherapyEnvironmentExposure ToFlexibilityGenerationsGenesGeneticGlucoseGlucose Metabolism
Grant awards (3)
A metabolic decision point in the progression of lymphoid malignancies$0
I01 · FY2023 · VA · contact PI
A metabolic decision point in the progression of lymphoid malignancies$0
I01 · FY2021 · VA · contact PI
A metabolic decision point in the progression of lymphoid malignancies$0
I01 · FY2021 · VA · contact PI